Metabolite

KNApSAcK Entry

id C00003394
Name Xanthatin
CAS RN 26791-73-1
Standard InChI InChI=1S/C15H18O3/c1-9-8-14-13(11(3)15(17)18-14)7-6-12(9)5-4-10(2)16/h4-6,9,13-14H,3,7-8H2,1-2H3/b5-4+/t9-,13+,14-/m0/s1
Standard InChI (Main Layer) InChI=1S/C15H18O3/c1-9-8-14-13(11(3)15(17)18-14)7-6-12(9)5-4-10(2)16/h4-6,9,13-14H,3,7-8H2,1-2H3

Cluster

Phytochemical cluster No. 38
KCF-S cluster No. 857

Link

ChEMBL

By standard InChI CHEMBL404466
By standard InChI Main Layer CHEMBL404466 CHEMBL1983676

KEGG

By LinkDB C09601

CTD

By CAS RN C022186

Human Protein / Gene in interaction

CTD interaction (11)

compound gene gene name gene description interaction interaction type form reference
pmid
C022186 891 CCNB1
CCNB
cyclin B1 xanthatin results in decreased expression of CCNB1 mRNA decreases expression
mRNA 21568272
C022186 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) xanthatin results in decreased expression of CDK1 mRNA decreases expression
mRNA 21568272
C022186 10912 GADD45G
CR6
DDIT2
GADD45gamma
GRP17
growth arrest and DNA-damage-inducible, gamma Acetylcysteine inhibits the reaction [xanthatin results in increased expression of GADD45G mRNA] decreases reaction
/ increases expression
mRNA 23313378
C022186 10912 GADD45G
CR6
DDIT2
GADD45gamma
GRP17
growth arrest and DNA-damage-inducible, gamma Acetylcysteine inhibits the reaction [[xanthatin results in increased expression of GADD45G mRNA] which results in increased abundance of Reactive Oxygen Species] decreases reaction
/ increases abundance
/ increases expression
mRNA 23313378
C022186 10912 GADD45G
CR6
DDIT2
GADD45gamma
GRP17
growth arrest and DNA-damage-inducible, gamma Acetylcysteine inhibits the reaction [xanthatin results in increased expression of GADD45G protein] decreases reaction
/ increases expression
protein 23313378
C022186 10912 GADD45G
CR6
DDIT2
GADD45gamma
GRP17
growth arrest and DNA-damage-inducible, gamma xanthatin results in increased expression of GADD45G mRNA increases expression
mRNA 21568272
23313378
C022186 10912 GADD45G
CR6
DDIT2
GADD45gamma
GRP17
growth arrest and DNA-damage-inducible, gamma [xanthatin results in increased expression of GADD45G mRNA] which results in increased abundance of Reactive Oxygen Species increases abundance
/ increases expression
mRNA 23313378
C022186 10912 GADD45G
CR6
DDIT2
GADD45gamma
GRP17
growth arrest and DNA-damage-inducible, gamma xanthatin results in increased expression of GADD45G protein increases expression
protein 23313378
C022186 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) xanthatin results in increased expression of HMOX1 mRNA increases expression
mRNA 21568272
C022186 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta xanthatin results in increased expression of IL1B mRNA increases expression
mRNA 21568272
C022186 7153 TOP2A
TOP2
TP2A
topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) xanthatin results in decreased activity of TOP2A protein decreases activity
protein 23313378

Related Disease

Diseases related to CTD interactions

1 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D001943 C022186 Breast Neoplasms therapeutic
21568272